Skip to content
Screener

Cash & Equivalents at other companies

VTR
VentasVTR
$183.61M+0.7%
Welltower logo
WelltowerWELL
$4.7B+34.3%
Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
$39.04M-94.7%
LTC Properties logo
LTC PropertiesLTC
$40.44M+431%
Strawberry Fields logo
Strawberry FieldsSTRW
$42.15M-56.2%
CareTrust logo
CareTrustCTRE
$49.27M-83.9%

Other financials

Income statement

See full
Revenue$115.1M+28.9%
Net income$40.1M+17.4%
EPS (diluted)$0.82+10.8%

Balance sheet

See full
Total debt$1.4B+8.4%
Total equity$1.5B+6.2%
Total assets$2.9B+3.8%

Cash flow

See full
Operating cash flow$53.4M+15.0%

Valuation

See full
Market cap$3.65B+7.6%
Enterprise value$5B+11.2%
P/E24.7×+0.9×
P/S9.1×-0.6×

Profitability

See full
Operating margin50.1%
Net margin36.9%-4.3pp
FCF margin70.1%

Returns & leverage

See full
Return on equity10.1%-0.5pp
Debt / equity0.9×0.0×

Where this comes from

Reported directly by National Health Investors in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: National Health Investors’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000877860-26-000135
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Payments of equity issuance costs(47)
Distributions paid to noncontrolling interests(289)(311)
Dividends paid to stockholders(44,439)(41,119)
Taxes paid related to net settlement of stock incentive awards(4,502)(128)
Net cash provided by financing activities55,770139,766
Increase in cash, cash equivalents and restricted cash5,324110,775
Cash, cash equivalents and restricted cash at the beginning of the period19,62426,502
Cash, cash equivalents and restricted cash at the end of the period$24,948$137,277

Item 1. Financial Statements

FAQ

What is National Health Investors's cash & equivalents?
National Health Investors (NHI) reported cash & equivalents of $24.95M in Q1 2026.
How has National Health Investors's cash & equivalents changed year-over-year?
National Health Investors's cash & equivalents decreased by 81.8% year-over-year, from $137.28M to $24.95M.
What is the long-term trend for National Health Investors's cash & equivalents?
Over 5 years (2020 to 2025), National Health Investors's cash & equivalents has grown at a -15.8% compound annual growth rate (CAGR), from $46.34M to $19.62M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about National Health Investors's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude